Haemonetics (HAE) Revenue Growth (1y) (2010 - 2026)
Haemonetics (HAE) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 6.08% |
| 10 | Haemonetics | 3.79 Bn | 3.54 Bn | 198.21 Mn | 4.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 4.76% |
| Dec 27, 2025 | -2.75% |
| Sep 27, 2025 | -5.27% |
| Jun 28, 2025 | -4.40% |
| Mar 29, 2025 | -3.70% |
| Dec 28, 2024 | 3.66% |
| Sep 28, 2024 | 8.59% |
| Jun 29, 2024 | 7.98% |
| Mar 30, 2024 | 12.77% |
| Dec 30, 2023 | 10.14% |
| Sep 30, 2023 | 6.96% |
| Jul 1, 2023 | 19.08% |
| Apr 1, 2023 | 14.87% |
| Dec 31, 2022 | 17.53% |
| Oct 1, 2022 | 24.01% |
| Jul 2, 2022 | 14.41% |
| Apr 2, 2022 | 17.76% |
| Jan 1, 2022 | 8.07% |
| Oct 2, 2021 | 14.52% |
| Jul 3, 2021 | 16.85% |